|

AK131 Clinical Trials

2 actively recruiting trials

Pipeline

Phase 1: 1Phase 2: 1

Top Sponsors

  • Fudan University1
  • Akeso1

Indications

  • Cancer2
  • Triple Negative Breast Cancer1
  • Solid Tumor1
  • Breast Cancer1

Other2 trials

A Study of AK131 in Patients With Advanced Solid Tumors
Phase 1
Reverse Triple Negative Immune Resistant Breast Cancer
Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.